相关实验视频
Updated: May 21, 2025

09:33
Methods to Classify Cytoplasmic Foci as Mammalian Stress Granules
Published on: May 12, 2017
14.5K
细胞脂酶A2决定了压力颗粒和化疗反应的细胞间异质性
Alexandra Redding1, Guillaume Fonteneau1, Stefan Heinrich2
1Thomas Jefferson University, Philadelphia, PA, United States.
Cancer discovery
|March 18, 2025
概括
癌细胞表现出压力颗粒 (SG) 异质性,受细胞周期状态的影响. 通过cPLA2抑制准G2相SG可以使胰腺癌对化疗敏感.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 分子瘤学分子瘤学
背景情况:
- 癌细胞异质性对有效治疗构成重大挑战.
- 压力颗粒 (SGs),适应性有机体,在癌细胞群体内显示不同的水平.
研究的目的:
- 研究细胞循环状态在调节应力颗粒异质性的作用.
- 阐明细胞循环依赖的SG形成背后的分子机制.
- 探索针对胰腺管道腺癌 (PDAC) 的SG的治疗潜力.
主要方法:
- 在不同细胞周期阶段对应力颗粒形成的分析.
- 调查卡斯帕酶3,依赖的脂酶A2 (cPLA2) 和15-deoxy-delta-prostaglandin-J2 (15d-PGJ2) 在调节SG水平中的相互作用.
- 在PDAC模型中评估cPLA2抑制与诱导G2置的化疗药物结合的疗效.
主要成果:
- 与G1/S阶段相比,在G2阶段细胞中压力颗粒的形成显著增加.
- 在G1/S阶段,卡斯帕酶3活性抑制CPLA2和15d-PGJ2的产生,而在G2阶段抑制卡斯帕酶3导致CPLA2活性和15d-PGJ2水平的增加.
- 在PDAC中观察到细胞周期依赖的SG异质性.
- 抑制cPLA2使PDAC细胞对诱导G2停滞的化疗药物敏感.
结论:
- 细胞周期状态通过Caspase 3-cPLA2-15d-PGJ2调节轴决定了应力颗粒的异质性.
- 通过抑制cPLA2来向G2阶段应力颗粒代表了对PDAC的有希望的治疗策略.
- 了解细胞周期依赖的SG形成对于解决癌症异质性和开发新型癌症治疗至关重要.
相关概念视频
IP3/DAG Signaling Pathway
11.8K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.8K
Phosphoinositides and PIPs
7.4K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
7.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Role of ER in the Secretory Pathway
5.1K
Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.1K
Amplifying Signals via Second Messengers
6.6K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
6.6K
Amplifying Signals via Enzymatic Cascade
8.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K

